Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The next frontier in managing obesity and T2D: The role of novel combinations for touchCARDIO

32:01
 
Share
 

Manage episode 468660698 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

touchEXPERT OPINIONS for touchCARDIO
Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D).
The experts

  • Dr Sue Pedersen, University of Calgary, Calgary, Canada
  • Prof. Carel le Roux, University College Dublin, Dublin, Ireland
  • Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA

This touchPODCAST is for healthcare professionals outside of the USA and UK.
This activity is funded by an independent medical education grant from Novo Nordisk A/S.

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:

www.touchCARDIO.com

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 468660698 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

touchEXPERT OPINIONS for touchCARDIO
Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D).
The experts

  • Dr Sue Pedersen, University of Calgary, Calgary, Canada
  • Prof. Carel le Roux, University College Dublin, Dublin, Ireland
  • Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA

This touchPODCAST is for healthcare professionals outside of the USA and UK.
This activity is funded by an independent medical education grant from Novo Nordisk A/S.

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:

www.touchCARDIO.com

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play